Yea Christopher - Insider Non-Derivative Transactions at KalVista Pharmaceuticals, Inc. (KALV) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Aug 23, 2024, Yea Christopher's relationship to KalVista Pharmaceuticals, Inc. (KALV) is Officer (CHIEF DEVELOPMENT OFFICER), and currently has 85,676 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other KALV insiders.

Data Source: SEC.
Yea Christopher - Insider Non-Derivative Transactions of KALV Common Stock
Yea Christopher - Insider Non-Derivative Transactions at KALV
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Aug 24, 2024 Sell -- (Common Stock) 1916 12.4 85676
Aug 23, 2024 M -- (Common Stock) 3125 0 87592
Aug 20, 2024 Sell -- (Common Stock) 7102 12.01 84467
Aug 18, 2024 M -- (Common Stock) 11495 0 91569
May 21, 2024 Sell -- (Common Stock) 11610 11.76 80074
May 18, 2024 M -- (Common Stock) 18789 0 91684
Feb 21, 2024 Sell -- (Common Stock) 12053 14.11 72895
Feb 18, 2024 M -- (Common Stock) 18788 0 84948
Feb 15, 2024 Sell -- (Common Stock) 39886 15.01 66160
Feb 12, 2024 Acquisition -- (Common Stock) 60000 0 106046
Nov 21, 2023 Sell -- (Common Stock) 7113 8.23 46046
Nov 18, 2023 M -- (Common Stock) 11497 0 53159
Aug 19, 2023 Sell -- (Common Stock) 7142 10.73 41662
Aug 18, 2023 M -- (Common Stock) 11494 0 48804
May 19, 2023 Sell -- (Common Stock) 2604 10.14 37310
May 18, 2023 M -- (Common Stock) 4205 0 39914
Feb 18, 2023 Sell -- (Common Stock) 2727 7.66 35709
Feb 18, 2023 M -- (Common Stock) 4204 0 38436